CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Improvement of sustained virologic response (SVR) in the treatment of chronic hepatitis c genotype 1 with PEG-IFNalpha-2b by ribavirin dose adjustments: evidence obtained from the german PEG-IFNα-2b observational study
DOI 10.1055/s-0029-1246566
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Mauss, E Zehnter, D Hüppe, M Manns, G Teuber, D Tarek, T Witthöft, B Möller, N Dikopoulos, J Brack, K Dach, M Bilzer, G Tossing
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Two peginterferon (weight-based PEG-IFNα-2b and fixed-dose PEG-IFNα-2a) and ribavirin (RBV) regimens approved for HCV treatment were recently compared in the IDEAL study. While overall SVR rates of pts infected with G 1 were similar with both regimens, a 10% difference was observed for pts weighing 75–85kg. The latter were treated either with PEG-IFNα-2b (1.5µg/kg/wk)+1000mg RBV/d or PEG-IFNα-2a (180µg/wk)+120…
Zitieren
Zitierempfehlung
S Mauss, E Zehnter, D Hüppe, M Manns, G Teuber, D Tarek, T Witthöft, B Möller, N Dikopoulos, J Brack, K Dach, M Bilzer, G Tossing (2010) Improvement of sustained virologic response (SVR) in the treatment of chronic hepatitis c genotype 1 with PEG-IFNalpha-2b by ribavirin dose adjustments: evidence obtained from the german PEG-IFNα-2b observational study. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0029-1246566
Mit CareLit weiterarbeiten